ストックスクリーナーアプリを入手
1.59
1.92%
0.03
前日終値:
$1.56
開ける：
$1.5301
24時間の取引高:
34,202
Relative Volume:
0.80
時価総額：
$11.45M
収益：
-
当期純損益:
$-7.50M
株価収益率:
-1.435
EPS:
-1.108
ネットキャッシュフロー:
$-23.55M
1週間 パフォーマンス:
+4.61%
1か月 パフォーマンス:
-21.67%
6か月 パフォーマンス:
-11.67%
1年 パフォーマンス:
+33.21%
1日の値動き範囲:
$1.5301
$1.62
1週間の範囲:
$1.48
$1.6219
52週間の値動き範囲:
$0.8288
$3.855
Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile
名前
Chemomab Therapeutics Ltd Adr
セクター
電話
972-77-331-0156
住所
KIRYAT ATIDIM, BUILDING 7, TEL AVIV
Compare CMMB vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CMMB
Chemomab Therapeutics Ltd Adr
|
1.59 | 11.45M | 0 | -7.50M | -23.55M | -1.108 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-13 | 開始されました | Maxim Group | Buy |
| 2024-05-06 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-12-19 | 再開されました | ROTH MKM | Buy |
Chemomab Therapeutics Ltd Adr (CMMB) 最新ニュース
Price to earnings forward of Chemomab Therapeutics Ltd. Sponsored ADR – MUN:2QV - TradingView
Enterprise value to EBIT forward of Chemomab Therapeutics Ltd. Sponsored ADR – MUN:2QV - TradingView
Chemomab Therapeutics Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:CMMB) - TradingView
2QV Forecast — Price Target — Prediction for 2027 - TradingView
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Chemomab Therapeutics (CMMB) flags going-concern risk and reliance on nebokitug - Stock Titan
Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Chemomab Therapeutics (CMMB) and Reviva Pharmaceuticals Holdings (RVPH) - The Globe and Mail
Chemomab Therapeutics (CMMB) to Release Quarterly Earnings on Monday - Defense World
Chemomab Therapeutics (NASDAQ:CMMB) Shares Down 4.5% – Time to Sell? - Defense World
Chemomab’s nebokitug shows disease-modifying potential in PSC trial - Investing.com
New Strong Buy Stocks for Oct. 23: MQ, GES and More - Nasdaq
SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study - Yahoo Finance
NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients - Yahoo Finance
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up - Yahoo Finance
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan - Yahoo Finance
RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - Yahoo Finance
TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals - Finviz
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain - Yahoo Finance
CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza - Yahoo Finance
KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure - Yahoo Finance
MRK Expands Tulisokibart Program in Three New Inflammatory Diseases - Nasdaq
Chemomab Therapeutics Ltd Share Price ADR Each Representing 80 Ord Shares SPON - Hargreaves Lansdown
Oppenheimer raises Chemomab stock price target to $25 on M&A potential - Investing.com
Jeff Jones Analyst Performance at Oppenheimer - MarketBeat
KURA Stock Rises More Than 15% This Past Week: Here's Why - Yahoo Finance
NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study - Yahoo Finance
CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer - The Globe and Mail
TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance
Aspire Biopharma (ASBP) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Chemomab Therapeutics to Present at October 2024 Investor Conferences By Investing.com - Investing.com
Entero Therapeutics (ENTO) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Chemomab Therapeutics (CMMB) Stock Forecast and Price Target 2026 - MarketBeat
Chemomab Therapeutics Ltd. Sponsored ADR Earnings and Revenue – NASDAQ:CMMB - TradingView — Track All Markets
Psyence Biomedical (PBM) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
PMGC (ELAB) Short Interest & Short Float | Updated May 2026 - MarketBeat
What's going on in today's pre-market session - ChartMill
GRI Bio (GRI) Short Interest & Short Float | Updated Apr 2026 $GRI - MarketBeat
Which stocks are moving before the opening bell on Tuesday? - ChartMill
Chemomab Therapeutics LtdADR (CMMB) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
What is the current Price Target and Forecast for Chemomab Therapeutics (CMMB) - Zacks Investment Research
IO Biotech (IOBT) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Top movers in Tuesday's session - ChartMill
These stocks are moving in today's pre-market session - ChartMill
Chemomab Therapeutics (CMMB) 10K Form and Latest SEC Filings 2026 - MarketBeat
HCW Biologics (HCWB) Short Interest & Short Float | Updated May 2026 - MarketBeat
Chemomab Therapeutics (CMMB) Short Interest & Short Float | Updated Jan 2026 - MarketBeat
What date does Chemomab Therapeutics's (CMMB) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
These stocks are moving in today's after hours session - ChartMill
CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Technical Analysis - Chartmill
Chemomab Therapeutics (CMMB) Institutional Ownership 2026 - MarketBeat
Chemomab Therapeutics Ltd Adr (CMMB) 財務データ
収益
当期純利益
現金流量
EPS
1.36%
大文字化:
|
ボリューム (24 時間):